Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders
- PMID: 29807322
- PMCID: PMC6374030
- DOI: 10.1016/j.jad.2018.05.005
Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders
Abstract
Background: Substantial research progress can be achieved if available clinical datasets can be mapped to the National Institute of Mental Health Research-Domain-Criteria (RDoC) constructs. This mapping would allow investigators to both explore more narrowly defined clinical phenotypes and the relationship of these phenotypes to biological markers and clinical outcomes approximating RDoC criteria.
Methods: Using expert review and consensus, we defined four major depression phenotypes based on specific RDoC constructs. Having matched these constructs to individual items from the Hamilton Depression Rating Scale and Quick Inventory of Depressive Symptomatology, we identified subjects meeting criteria for each of these phenotypes from two large clinical trials of patients treated for major depression. In a post hoc analysis, we evaluated the overall treatment response based on the phenotypes: Core Depression (CD), Anxiety (ANX), and Neurovegetative Symptoms of Melancholia (NVSM) and Atypical Depression (NVSAD).
Results: The phenotypes were prevalent (range 10.5-52.4%, 50% reduction range 51.9-82.9%) and tracked with overall treatment response. Although the CD phenotype was associated with lower rates of remission in both cohorts, this was mainly driven by baseline symptom severity. However, when controlling for baseline severity, patients with the ANX phenotype had a significantly lower rate of remission.
Limitations: The lack of replication between the studies of the phenotypes' treatment prediction value reflects important variability across studies that may limit generalizability.
Conclusion: Further work evaluating biological markers associated with these phenotypes is needed for further RDoC concept development.
Keywords: Anxiety; Core depression; Major depressive disorder; Neurovegetative symptoms of melancholia and atypical depression; Research domain criteria.
Copyright © 2018 Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflicts of Interest:
none
Figures
References
-
- Angst J, Gamma A, Benazzi F, Silverstein B, Ajdacic–Gross V, Eich D, Rössler W, 2006. Atypical depressive syndromes in varying definitions. European Archives of Psychiatry and Clinical Neuroscience 256, 44–54. - PubMed
-
- Arnow BA, Blasey C, Williams LM, Palmer DM, Rekshan W, Schatzberg AF, Etkin A, Kulkarni J, Luther JF, Rush AJ, 2015. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial. The American journal of psychiatry 172, 743–750. - PubMed
-
- Bagby RM, Ryder AG, Schuller DR, Marshall MB, 2004. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? The American journal of psychiatry 161, 2163–2177. - PubMed
-
- Beck AT, Steer RA, Carbin MG, 1988. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review 8, 77–100.
-
- Benazzi F, 2002. Can only reversed vegetative symptoms define atypical depression? Eur Arch Psychiatry Clin Neurosci 252, 288–293. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
